Jobs appears closer to returning to work at Apple

Jun 24, 2009 By JANET BLAKE , Associated Press Writer
FILE - In this Sept. 9, 2009 file photo, shows Apple CEO Steve Jobs smiling at a conference in San Francisco. A Memphis, Tenn., hospital is confirming that Apple founder Steve Jobs received a liver transplant and that he has an "excellent prognosis." Dr. James D. Eason made the announcement Tuesday June 23, 2009 on the hospital's Web site. He is program director at Methodist University Hospital Transplant Institute and chief of transplantation. (AP Photo/Paul Sakuma, file)

(AP) -- Apple co-founder and CEO Steve Jobs appears to be a step closer to returning to work, as a doctor gave him an "excellent prognosis" after receiving a liver transplant at a Tennessee hospital.

"He received a liver transplant because he was ... the sickest patient on the waiting list at the time a became available," Dr. James D. Eason, chief of transplantation at Methodist University Hospital Transplant Institute in Memphis, said in a statement late Tuesday. "Mr. Jobs is now recovering well and has an excellent prognosis."

Eason said in a news release posted on the hospital's Web site that when Jobs received the transplant, he was in end-stage .

The doctor made the disclosure with Jobs' permission. Jobs has been on a medical leave since January.

Eason did not reveal when the operation took place, citing patient privacy. However, The Wall Street Journal reported it was two months ago.

did not confirm the newspaper's report, and has said only that Jobs is looking forward to returning to Apple - which he started in 1976 - at the end of June.

Eason said the hospital could not reveal further information on the specifics of the transplant.

"That's all that we are giving out at this time," hospital spokeswoman Ruth Ann Hale told The Associated Press.

Wall Street has grappled with the implications of Jobs' health since August 2004, when investors learned the CEO had kept a cancer diagnosis secret until after he underwent surgery. The company's past silence on matters of Jobs' health made shareholders jittery when he appeared increasingly, even alarmingly, thin last year.

Investors sent the stock tumbling 5 percent to its lowest point in a year on a rumor last October that Jobs had suffered a heart attack.

Then shares slipped 2 percent in December when Apple said that Jobs would not speak as usual the next month at the annual Macworld conference, then bounced up 4 percent on Jan. 5 when Jobs explained his weight loss as a treatable hormone imbalance. They sank 7 percent a week later after Apple said he would be taking six months off because his medical problems were more complex than he initially thought.

Since then, Wall Street's whiplash has had time to heal, especially because Apple's stock has weathered the recession better than those of most of its competitors.

Cupertino, California-based Apple put Tim Cook, its chief operating officer, at the helm during Jobs' absence.

Apple shares were up 99 cents at $135 in premarket trading Wednesday. They are up more than 70 percent from their 52-week low of $78.20 on Jan. 20.

---

On the Net:

http://www.methodisthealth.org

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Ticketfly buying WillCall for on-premise data

add to favorites email to friend print save as pdf

Related Stories

Apple fans are prepared for a part-time Jobs

Jun 22, 2009

(AP) -- Five and a half months ago, word that Steve Jobs would only work part-time as he recovered from a liver transplant would have sent investors into a selling frenzy, so closely linked was Apple's charismatic ...

Apple CEO gets liver transplant: report

Jun 20, 2009

Apple chief executive Steve Jobs, on medical leave since January for treatment of an undisclosed condition, received a liver transplant about two months ago in Tennessee, The Wall Street Journal reported ...

Business 101: Must Apple discuss CEO Jobs' health?

Jun 22, 2009

(AP) -- This week, Apple Inc. wasn't shy about touting the sales of its latest mobile device. But the company didn't say anything confirming reports from over the weekend that co-founder and CEO Steve Jobs had a liver transplant ...

Apple 2Q profit gains 15 percent, beats Street

Apr 22, 2009

(AP) -- Strong sales of the iPhone helped Apple Inc. lift its quarterly profit 15 percent, well ahead of Wall Street's expectations Wednesday despite the global economic downturn.

Recommended for you

Ticketfly buying WillCall for on-premise data

15 hours ago

Ticketfly Inc., a San Francisco-based technology company among several posing a challenge to Ticketmaster, is acquiring WillCall Inc., a crosstown rival that turns your smartphone into a mobile wallet at live events.

HP revenue inches up after years of decline

Aug 20, 2014

Hewlett-Packard on Wednesday reported that its quarterly revenue rose for the first time in three years, nudged by improved computer sales everywhere except Russia and China.

Restaurants experimenting with pay-in-advance tickets

Aug 20, 2014

With restaurant patrons increasingly jumping on the Internet to make reservations, some high-end eateries here and across the country are adding a new tech wrinkle: having their clientele pay for their meal in advance using ...

Chip maker Infineon to buy California firm for $3B (Update)

Aug 20, 2014

German chip maker Infineon Technologies AG says it has agreed to pay $3 billion in cash for California-based semiconductor firm International Rectifier, which produces power-management components used in everything from cars ...

User comments : 0